2023 Q3 Form 10-Q Financial Statement
#000169853023000079 Filed on July 14, 2023
Income Statement
| Concept | 2023 Q3 | 2023 Q1 | 2022 Q1 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $2.565M |
| YoY Change | -100.0% | -100.0% | 157.27% |
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $2.397M | $2.558M | $3.162M |
| YoY Change | -0.79% | -19.1% | 9.41% |
| % of Gross Profit | |||
| Research & Development | $0.00 | $1.981M | $7.140M |
| YoY Change | -100.0% | -72.25% | -30.42% |
| % of Gross Profit | |||
| Depreciation & Amortization | $147.0K | $251.0K | $302.0K |
| YoY Change | -49.13% | -16.89% | 16.15% |
| % of Gross Profit | |||
| Operating Expenses | $3.317M | $4.539M | $10.30M |
| YoY Change | -54.06% | -55.94% | -21.68% |
| Operating Profit | -$3.317M | -$4.539M | -$7.737M |
| YoY Change | -36.27% | -41.33% | -36.36% |
| Interest Expense | $0.00 | $28.00K | $595.0K |
| YoY Change | -95.29% | 45.48% | |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$1.939M | $104.0K | -$611.0K |
| YoY Change | -4408.89% | -117.02% | 90.94% |
| Pretax Income | -$5.256M | -$4.407M | -$8.348M |
| YoY Change | 1.86% | -47.21% | -33.09% |
| Income Tax | $0.00 | $0.00 | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$5.256M | -$4.407M | -$8.348M |
| YoY Change | 1.86% | -47.21% | -33.09% |
| Net Earnings / Revenue | -325.46% | ||
| Basic Earnings Per Share | -$0.61 | -$0.70 | -$0.07 |
| Diluted Earnings Per Share | -$0.61 | -$0.70 | -$0.07 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 8.648M shares | 8.367M shares | 120.9M shares |
| Diluted Shares Outstanding | 8.650M shares | 6.289M shares | 120.9M shares |
Balance Sheet
| Concept | 2023 Q3 | 2023 Q1 | 2022 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $922.0K | $9.960M | $26.38M |
| YoY Change | -94.11% | -62.25% | -60.85% |
| Cash & Equivalents | $922.0K | $9.960M | $23.89M |
| Short-Term Investments | $2.494M | ||
| Other Short-Term Assets | $1.457M | $1.317M | $2.798M |
| YoY Change | -6.12% | -52.93% | -55.59% |
| Inventory | |||
| Prepaid Expenses | $0.00 | $51.00K | $1.175M |
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $3.090M | $11.28M | $29.18M |
| YoY Change | -82.03% | -61.36% | -60.56% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $61.00K | $9.356M | $3.612M |
| YoY Change | -97.99% | 159.03% | -11.73% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $3.092M | $3.310M | $1.321M |
| YoY Change | 142.13% | 150.57% | -7.36% |
| Total Long-Term Assets | $9.860M | $12.67M | $12.71M |
| YoY Change | -16.04% | -0.38% | -8.93% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $3.090M | $11.28M | $29.18M |
| Total Long-Term Assets | $9.860M | $12.67M | $12.71M |
| Total Assets | $12.95M | $23.94M | $41.90M |
| YoY Change | -55.26% | -42.85% | -52.36% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $865.0K | $452.0K | $1.918M |
| YoY Change | -5.98% | -76.43% | -35.55% |
| Accrued Expenses | $1.356M | $1.477M | $3.227M |
| YoY Change | -55.04% | -54.23% | 32.2% |
| Deferred Revenue | $16.22M | ||
| YoY Change | 120.75% | ||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $0.00 | ||
| YoY Change | |||
| Total Short-Term Liabilities | $2.221M | $2.729M | $21.36M |
| YoY Change | -91.36% | -87.22% | 67.37% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| Other Long-Term Liabilities | $6.231M | $6.595M | $0.00 |
| YoY Change | -100.0% | ||
| Total Long-Term Liabilities | $6.231M | $6.595M | $0.00 |
| YoY Change | -100.0% | ||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $2.221M | $2.729M | $21.36M |
| Total Long-Term Liabilities | $6.231M | $6.595M | $0.00 |
| Total Liabilities | $8.452M | $9.324M | $38.66M |
| YoY Change | -74.11% | -75.88% | 1.99% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$188.1M | -$177.1M | -$178.4M |
| YoY Change | -1.55% | -0.76% | 50.63% |
| Common Stock | $1.000K | $1.000K | $12.00K |
| YoY Change | -91.67% | 33.33% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $4.498M | $14.62M | $3.236M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $12.95M | $23.94M | $41.90M |
| YoY Change | -55.26% | -42.85% | -52.36% |
Cashflow Statement
| Concept | 2023 Q3 | 2023 Q1 | 2022 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$5.256M | -$4.407M | -$8.348M |
| YoY Change | 1.86% | -47.21% | -33.09% |
| Depreciation, Depletion And Amortization | $147.0K | $251.0K | $302.0K |
| YoY Change | -49.13% | -16.89% | 16.15% |
| Cash From Operating Activities | -$1.411M | -$3.318M | -$12.76M |
| YoY Change | -78.45% | -73.99% | -13.86% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $0.00 | $0.00 | $6.000K |
| YoY Change | -100.0% | -97.33% | |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $1.000K | $106.0K | $2.001M |
| YoY Change | -99.9% | -94.7% | -87.11% |
| Cash From Investing Activities | $1.000K | $106.0K | $1.995M |
| YoY Change | -99.9% | -94.69% | -86.96% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | $0.00 | $7.500M | |
| YoY Change | -100.0% | ||
| Cash From Financing Activities | -5.000K | 4.595M | -$7.993M |
| YoY Change | 150.0% | -157.49% | -1563.92% |
| NET CHANGE | |||
| Cash From Operating Activities | -1.411M | -3.318M | -$12.76M |
| Cash From Investing Activities | 1.000K | 106.0K | $1.995M |
| Cash From Financing Activities | -5.000K | 4.595M | -$7.993M |
| Net Change In Cash | -1.415M | 1.383M | -$18.75M |
| YoY Change | -74.51% | -107.37% | -1913.73% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$1.411M | -$3.318M | -$12.76M |
| Capital Expenditures | $0.00 | $0.00 | $6.000K |
| Free Cash Flow | -$1.411M | -$3.318M | -$12.76M |
| YoY Change | -78.45% | -74.0% | -15.11% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2023Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1317000 | usd |
| CY2023Q1 | us-gaap |
Assets Current
AssetsCurrent
|
11277000 | usd |
| CY2023Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2279000 | usd |
| CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2023Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2023Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
| CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
| CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
8371462 | shares |
| CY2023Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | usd |
| CY2023Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
191674000 | usd |
| CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-177056000 | usd |
| CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
14619000 | usd |
| CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
23943000 | usd |
| CY2023Q1 | xcur |
Revenue From Contract With Customer Net Of Cumulative Catch Up Adjustment
RevenueFromContractWithCustomerNetOfCumulativeCatchUpAdjustment
|
0 | usd |
| CY2022Q1 | xcur |
Revenue From Contract With Customer Net Of Cumulative Catch Up Adjustment
RevenueFromContractWithCustomerNetOfCumulativeCatchUpAdjustment
|
2565000 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
7077000 | usd |
| CY2023Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3310000 | usd |
| CY2023Q1 | us-gaap |
Assets
Assets
|
23943000 | usd |
| CY2023Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
452000 | usd |
| CY2023Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1477000 | usd |
| CY2023Q1 | xcur |
Common Stock Warrant Liability Current
CommonStockWarrantLiabilityCurrent
|
800000 | usd |
| CY2022Q4 | xcur |
Common Stock Warrant Liability Current
CommonStockWarrantLiabilityCurrent
|
0 | usd |
| CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2023Q1 | us-gaap |
Revenues
Revenues
|
0 | usd |
| CY2022Q1 | us-gaap |
Revenues
Revenues
|
2565000 | usd |
| CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1981000 | usd |
| CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2558000 | usd |
| CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
4539000 | usd |
| CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4539000 | usd |
| CY2023Q1 | us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
17000 | usd |
| CY2023Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
11000 | usd |
| CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
0 | usd |
| CY2022Q1 | us-gaap |
Interest Expense
InterestExpense
|
595000 | usd |
| CY2022Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-20000 | usd |
| CY2022Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-611000 | usd |
| CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-8348000 | usd |
| CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8348000 | usd |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.70 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.70 | |
| CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-2.07 | |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6288952 | shares |
| CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4031316 | shares |
| CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4031316 | shares |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4407000 | usd |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8348000 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
0 | usd |
| CY2022Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-3000 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
0 | usd |
| CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-3000 | usd |
| CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-4407000 | usd |
| CY2022Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-8351000 | usd |
| CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
308000 | usd |
| CY2023Q1 | xcur |
Adjustments To Additional Paid In Capital Decrease Related To Reclassification
AdjustmentsToAdditionalPaidInCapitalDecreaseRelatedToReclassification
|
800000 | usd |
| CY2023Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
-1000 | usd |
| CY2023Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
4597000 | usd |
| CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
11232000 | usd |
| CY2022Q1 | xcur |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
14000 | usd |
| CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
342000 | usd |
| CY2022Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
-1000 | usd |
| CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-3000 | usd |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8348000 | usd |
| CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3236000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4407000 | usd |
| CY2023Q1 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
251000 | usd |
| CY2022Q1 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
302000 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
308000 | usd |
| CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
342000 | usd |
| CY2023Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
0 | usd |
| CY2022Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
477000 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
180000 | usd |
| CY2022Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
169000 | usd |
| CY2023Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
0 | usd |
| CY2022Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
1000 | usd |
| CY2023Q1 | us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
-105000 | usd |
| CY2022Q1 | us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
19000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-157000 | usd |
| CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-1727000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-180000 | usd |
| CY2022Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-4000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
91000 | usd |
| CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1495000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
199000 | usd |
| CY2022Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-3237000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
0 | usd |
| CY2022Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-2565000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-172000 | usd |
| CY2022Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-150000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3318000 | usd |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-12756000 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
0 | usd |
| CY2022Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
1499000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
|
0 | usd |
| CY2022Q1 | us-gaap |
Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
|
3500000 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | usd |
| CY2022Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
6000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
106000 | usd |
| CY2022Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
106000 | usd |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
1995000 | usd |
| CY2023Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
0 | usd |
| CY2022Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
7500000 | usd |
| CY2023Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | usd |
| CY2022Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
506000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
5440000 | usd |
| CY2022Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd |
| CY2023Q1 | xcur |
Payments Of Common Stock Financing Costs
PaymentsOfCommonStockFinancingCosts
|
843000 | usd |
| CY2022Q1 | xcur |
Payments Of Common Stock Financing Costs
PaymentsOfCommonStockFinancingCosts
|
0 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | usd |
| CY2022Q1 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
14000 | usd |
| CY2023Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
2000 | usd |
| CY2022Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4595000 | usd |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-7993000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1383000 | usd |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-18754000 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9777000 | usd |
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
43844000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
11160000 | usd |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
25090000 | usd |
| CY2023Q1 | xcur |
Reclassification Of Common Stock Warrants To Liability
ReclassificationOfCommonStockWarrantsToLiability
|
800000 | usd |
| CY2022Q1 | xcur |
Reclassification Of Common Stock Warrants To Liability
ReclassificationOfCommonStockWarrantsToLiability
|
0 | usd |
| CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9960000 | usd |
| CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8577000 | usd |
| CY2023Q1 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
1200000 | usd |
| CY2022Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
1200000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
11160000 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9777000 | usd |
| CY2023Q1 | xcur |
Retained Earnings Accumulated Deficit Inceptionto Date
RetainedEarningsAccumulatedDeficitInceptiontoDate
|
-195893000 | usd |
| CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9960000 | usd |
| CY2023Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on certain assumptions which it believes are reasonable in the circumstances and while actual results could differ from those estimates, management does not believe that any change in those assumptions in the near term would have a significant effect on the Company’s financial position, results of operations or cash flows. Actual results in future periods could differ from those estimates.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates include the recording of its warrant liability. The Company calculated its warrant liability based on the Black-Scholes Model, see Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholders’ Equity</span>, for further details. | |
| CY2023Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
51000 | usd |
| CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
213000 | usd |
| CY2023Q1 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
750000 | usd |
| CY2022Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
408000 | usd |
| CY2023Q1 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
516000 | usd |
| CY2022Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
853000 | usd |
| CY2023Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1317000 | usd |
| CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1474000 | usd |
| CY2023Q1 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
1200000 | usd |
| CY2022Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
1200000 | usd |
| CY2023Q1 | xcur |
Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
|
2106000 | usd |
| CY2022Q4 | xcur |
Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
|
2252000 | usd |
| CY2023Q1 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
4000 | usd |
| CY2022Q4 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
38000 | usd |
| CY2023Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3310000 | usd |
| CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3490000 | usd |
| CY2023Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
6025000 | usd |
| CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
6180000 | usd |
| CY2023Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3746000 | usd |
| CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3650000 | usd |
| CY2023Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2279000 | usd |
| CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2530000 | usd |
| CY2023Q1 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
251000 | usd |
| CY2022Q1 | us-gaap |
Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
|
302000 | usd |
| CY2023Q1 | xcur |
Accrued Clinical Contract Research And Manufacturing Costs Current
AccruedClinicalContractResearchAndManufacturingCostsCurrent
|
10000 | usd |
| CY2022Q4 | xcur |
Accrued Clinical Contract Research And Manufacturing Costs Current
AccruedClinicalContractResearchAndManufacturingCostsCurrent
|
48000 | usd |
| CY2023Q1 | us-gaap |
Restructuring Reserve Current
RestructuringReserveCurrent
|
0 | usd |
| CY2022Q4 | us-gaap |
Restructuring Reserve Current
RestructuringReserveCurrent
|
48000 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
561000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
539000 | usd |
| CY2023Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
184000 | usd |
| CY2022Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
32000 | usd |
| CY2023Q1 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
209000 | usd |
| CY2022Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
209000 | usd |
| CY2023Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
513000 | usd |
| CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
402000 | usd |
| CY2023Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1477000 | usd |
| CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1278000 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
326000 | usd |
| CY2022Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
326000 | usd |
| CY2023Q1 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
332000 | usd |
| CY2022Q1 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
341000 | usd |
| CY2023Q1 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
0 | usd |
| CY2022Q1 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
13000 | usd |
| CY2023Q1 | us-gaap |
Lease Cost
LeaseCost
|
658000 | usd |
| CY2022Q1 | us-gaap |
Lease Cost
LeaseCost
|
680000 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
646000 | usd |
| CY2022Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
872000 | usd |
| CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2023Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2023Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2023Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2023Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
| CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
| CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
8371462 | shares |
| CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
8371462 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4965901 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4965901 | shares |
| CY2023Q1 | xcur |
Common Stock Voting Rights For Each Share
CommonStockVotingRightsForEachShare
|
1 | vote |
| CY2023Q1 | xcur |
Number Of Members Designated To Board
NumberOfMembersDesignatedToBoard
|
3 | member |
| CY2022Q3 | xcur |
Registration Rights Agreement Required Filing Term
RegistrationRightsAgreementRequiredFilingTerm
|
P90D | |
| CY2022Q3 | xcur |
Registration Rights Agreement Liquidation Damages Payable As A Percent Of Amount Invested If Filed Late
RegistrationRightsAgreementLiquidationDamagesPayableAsAPercentOfAmountInvestedIfFiledLate
|
0.005 | |
| CY2022Q3 | xcur |
Registration Rights Agreement Liquidation Damages Payable If Filed Late Measurement Term
RegistrationRightsAgreementLiquidationDamagesPayableIfFiledLateMeasurementTerm
|
P30D | |
| CY2021Q4 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P5Y | |
| CY2021Q4 | xcur |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
11478000 | usd |
| CY2021Q4 | xcur |
Proceeds From Issuance Of Common Stock And Warrants Net Of Placement Agent Fee And Other Offering Expenses Payable
ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfPlacementAgentFeeAndOtherOfferingExpensesPayable
|
10226000 | usd |
| CY2021Q4 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P5Y | |
| CY2021Q4 | xcur |
Class Of Warrant Or Right Ownership Percentage Limitation
ClassOfWarrantOrRightOwnershipPercentageLimitation
|
0.0499 | |
| CY2021Q4 | xcur |
Class Of Warrant Or Right Ownership Percentage Limitation At Election Of Purchaser
ClassOfWarrantOrRightOwnershipPercentageLimitationAtElectionOfPurchaser
|
0.0999 | |
| CY2021Q4 | xcur |
Class Of Warrant Or Right Ownership Percentage Limitation
ClassOfWarrantOrRightOwnershipPercentageLimitation
|
0.0499 | |
| CY2021Q4 | xcur |
Class Of Warrant Or Right Ownership Percentage Limitation At Election Of Purchaser
ClassOfWarrantOrRightOwnershipPercentageLimitationAtElectionOfPurchaser
|
0.0999 | |
| CY2023Q1 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
576261 | shares |
| CY2023Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
8.1031 | |
| CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
308000 | usd |
| CY2022Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
342000 | usd |
| CY2023Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
1415000 | usd |
| CY2023Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y7M6D | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0383 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0383 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.010 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.010 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
|
1.010 | |
| CY2023Q1 | xcur |
Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Forfeiture Rate
SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
|
0.05 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
| CY2023Q1 | us-gaap |
Share Price
SharePrice
|
1.58 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
1.58 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.26 | |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
222833 | shares |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.74 | |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4407000 | usd |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8348000 | usd |
| CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y6M | |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
10000 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.58 | |
| CY2023Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
29427 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
5.55 | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
203406 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.46 | |
| CY2023Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y8M12D | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
84469 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
5.40 | |
| CY2023Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P3Y6M | |
| CY2023Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
196229 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
4.49 | |
| CY2023Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P6Y7M6D | |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
0 | usd |
| CY2022Q2 | xcur |
Stock Option Exercise Price
StockOptionExercisePrice
|
5.51 | |
| CY2022Q2 | xcur |
Stock Option Exercise Price
StockOptionExercisePrice
|
5.51 | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
233224 | shares |
| CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
| CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
| CY2023Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
| CY2022Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6288952 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6288952 | shares |
| CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4031316 | shares |
| CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4031316 | shares |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.70 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.70 | |
| CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-2.07 | |
| CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-2.07 | |
| CY2022Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
0 | shares |
| CY2022Q4 | xcur |
Class Of Warrant Or Right Outstanding Fair Value Per Share
ClassOfWarrantOrRightOutstandingFairValuePerShare
|
0 | |
| CY2022Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
0 | usd |
| CY2023Q1 | xcur |
Class Of Warrant Or Right Additions
ClassOfWarrantOrRightAdditions
|
526000 | shares |
| CY2023Q1 | xcur |
Class Of Warrant Or Right Additions Fair Value Per Share
ClassOfWarrantOrRightAdditionsFairValuePerShare
|
1.52 | |
| CY2023Q1 | xcur |
Warrants And Rights Outstanding Additions
WarrantsAndRightsOutstandingAdditions
|
800000 | usd |
| CY2023Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
526000 | shares |
| CY2023Q1 | xcur |
Class Of Warrant Or Right Outstanding Fair Value Per Share
ClassOfWarrantOrRightOutstandingFairValuePerShare
|
1.52 | |
| CY2023Q1 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
800000 | usd |
| CY2023Q1 | xcur |
Aggregate Payments Made To Date For License Agreements
AggregatePaymentsMadeToDateForLicenseAgreements
|
11540000 | usd |
